These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28284524)

  • 21. Prevalence of undiagnosed atrial fibrillation and of that not being treated with anticoagulant drugs: the AFABE study.
    Clua-Espuny JL; Lechuga-Duran I; Bosch-Princep R; Roso-Llorach A; Panisello-Tafalla A; Lucas-Noll J; López-Pablo C; Queralt-Tomas L; Giménez-Garcia E; González-Rojas N; Gallofré López M
    Rev Esp Cardiol (Engl Ed); 2013 Jul; 66(7):545-52. PubMed ID: 24776203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do CHA2 DS2 VASc and HAS-BLED scores influence 'real-world' anticoagulation management in atrial fibrillation? 1556 patient registry from the reference cardiology centre.
    Lopatowska P; Tomaszuk-Kazberuk A; Mlodawska E; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S; Musial WJ
    Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1297-303. PubMed ID: 26419506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA Study.
    Moreno-Arribas J; Bertomeu-González V; Anguita-Sanchez M; Cequier Á; Muñiz J; Castillo J; Sanchis J; Roldán I; Marín F; Bertomeu-Martínez V;
    J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):150-6. PubMed ID: 26229096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Factors, Co-Morbidities and Treatment of In-Hospital Patients with Atrial Fibrillation in Bulgaria.
    Naydenov S; Runev N; Manov E; Vasileva D; Rangelov Y; Naydenova N
    Medicina (Kaunas); 2018 May; 54(3):. PubMed ID: 30344265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial fibrillation in patients with haemophilia: a cross-sectional evaluation in Europe.
    Schutgens RE; Klamroth R; Pabinger I; Malerba M; Dolan G;
    Haemophilia; 2014 Sep; 20(5):682-6. PubMed ID: 24724839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and antithrombotic management of atrial fibrillation in hospitalised patients.
    Berti D; Moors E; Moons P; Heidbuchel H
    Heart; 2015 Jun; 101(11):884-93. PubMed ID: 25872523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic.
    Lee SI; Sayers M; Lip GY; Lane DA
    Int J Clin Pract; 2015 Nov; 69(11):1341-8. PubMed ID: 26234557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk-adapted anticoagulation in atrial fibrillation in Germany, Austria and Switzerland - an analysis from the PREFER-in-AF study].
    Steffel J; Gwechenberger M; Müller MW; Ammentorp B; Darius H; Kirchhof P
    Dtsch Med Wochenschr; 2015 Nov; 140(23):e247-55. PubMed ID: 26583826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of anticoagulation treatments in non-valvular atrial fibrillation patients diagnosed in a basic health area.
    Aguilera Alcaraz BM; Abellán Huerta J; Carbayo Herencia JA; Ariza Copado C; Hernández Menárguez F; Abellán Alemán J
    Clin Investig Arterioscler; 2018; 30(2):56-63. PubMed ID: 29246471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics and outcomes of atrial fibrillation and flutter at the Aga Khan University Hospital, Nairobi.
    Shavadia J; Yonga G; Mwanzi S; Jinah A; Moriasi A; Otieno H
    Cardiovasc J Afr; 2013 Mar; 24(2):6-9. PubMed ID: 23612946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of antithrombotics in atrial fibrillation in Africa, Europe, Asia and South America: insights from the International RealiseAF Survey.
    Gamra H; Murin J; Chiang CE; Naditch-Brûlé L; Brette S; Steg PG;
    Arch Cardiovasc Dis; 2014 Feb; 107(2):77-87. PubMed ID: 24556189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists: Antithrombotic Agents in Atrial Fibrillation (ATA-AF) survey.
    Berisso MZ; Fabbri G; Gonzini L; Caruso D; Fontanella A; Pellegrini F; Silvestri N; Vincenti A; Mathieu G; Di Pasquale G;
    J Cardiovasc Med (Hagerstown); 2014 Aug; 15(8):626-35. PubMed ID: 24978662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation.
    Lip GY; Laroche C; Boriani G; Cimaglia P; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Popescu MI; Tica O; Hellum CF; Mortensen B; Tavazzi L; Maggioni AP
    Europace; 2015 Jan; 17(1):24-31. PubMed ID: 24957921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation.
    Andrade JG; Verma A; Mitchell LB; Parkash R; Leblanc K; Atzema C; Healey JS; Bell A; Cairns J; Connolly S; Cox J; Dorian P; Gladstone D; McMurtry MS; Nair GM; Pilote L; Sarrazin JF; Sharma M; Skanes A; Talajic M; Tsang T; Verma S; Wyse DG; Nattel S; Macle L;
    Can J Cardiol; 2018 Nov; 34(11):1371-1392. PubMed ID: 30404743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry.
    Chiang CE; Naditch-Brûlé L; Murin J; Goethals M; Inoue H; O'Neill J; Silva-Cardoso J; Zharinov O; Gamra H; Alam S; Ponikowski P; Lewalter T; Rosenqvist M; Steg PG
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):632-9. PubMed ID: 22787011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of atrial fibrillation in the emergency room and in the cardiology ward: the BLITZ AF study.
    Gulizia MM; Cemin R; Colivicchi F; De Luca L; Di Lenarda A; Boriani G; Di Pasquale G; Nardi F; Scherillo M; Lucci D; Fabbri G; Maggioni AP;
    Europace; 2019 Feb; 21(2):230-238. PubMed ID: 30060174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation.
    Bassand JP; Accetta G; Al Mahmeed W; Corbalan R; Eikelboom J; Fitzmaurice DA; Fox KAA; Gao H; Goldhaber SZ; Goto S; Haas S; Kayani G; Pieper K; Turpie AGG; van Eickels M; Verheugt FWA; Kakkar AK;
    PLoS One; 2018; 13(1):e0191592. PubMed ID: 29370229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial fibrillation in older inpatients: are there any differences in clinical characteristics and pharmacological treatment between the frail and the non-frail?
    Nguyen TN; Cumming RG; Hilmer SN
    Intern Med J; 2016 Jan; 46(1):86-95. PubMed ID: 26388116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotics in atrial fibrillation and coronary disease.
    Velagapudi P; Turagam MK; Agrawal H; Mittal M; Kocheril AG; Aggarwal K
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):977-86. PubMed ID: 25046150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.